DNA amplification was detected at chromosomal regions 17q21.1(harboring HER-2), 11q13.3 (CCND1), and 11q13 (FGF4) in four, three, and three tumors, respectively, though the amplification was not correlated with any clinicopathological feature of the gastric cancers. Here, CCND1 is linked to gastric cancer.